Company intelligence / Profile preview

X-Therma Inc.

Hercules (San Francisco Bay Area), California, United Statesx-therma.com ↗

Ownership: Private
Development stage: Preclinical

Overview

X-Therma has developed XT-ViVo and TimeSeal Organ Transport Device which received FDA Breakthrough Device designation in 2022. The company has successfully conducted multiple 48-hour transatlantic organ transports between Baltimore and Innsbruck using their subzero preservation technology[5].

Therapeutic areas: OtherRare DiseasesImmunology
Modalities: Biopreservation solutionsorgan preservation technology
Industry: Therapeutic Medical Devices

Drug pipeline

3 assets

XT-Thrive

Commercial

Indications: Cell preservation, Tissue preservation

2 more assets in the full pipeline.

Request access →

Partnerships

Johns Hopkins University[1]

Beyond the preview

Go deeper on X-Therma Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on X-Therma Inc..

Explore the full profile